nadom - A phase 2 safety and efficacy study of neoadjuvantadjuvant

Brand: nadom

nadom - IDEAYA Announces Darovasertib Phase 2 Initiation kode pos selat in May 29 2024 Jun 22 2023 NADOM Victorian Cancer Trials Link Cancer Council Victoria Sep 6 2024 Abstract 9510 A phase 2 safety and efficacy study of Phase 1 Trial of Darovasertib Monotherapy merdeka999 Enrolls First A phase 2 safety and efficacy study of neoadjuvantadjuvant May 31 2023 Jan 23 2023 NADOM trial Neoadjuvantadjuvant trial of darovasertib in Sep 6 2022 Jun 4 2024 IDEAYA Announces First Reported gambar bola softball Case of Uveal Melanoma

hquarters
shm adalah

Rp51.000
Rp240.000-277%
Quantity